Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone in adolescent eating disorders
NCT05073679Phase 3Terminated
- Start
- Apr 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in anorexia nervosa (AN), bulimia nervosa (BN), purging disorder (PD). Started Apr 2022; status: terminated.
02
Drugs
naltrexone
03
Conditions
anorexia nervosa (AN)bulimia nervosa (BN)purging disorder (PD)
Beyond the preview
Go deeper on NCT05073679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073679.